Cosmo Pharmaceuticals N.V. (SWX: COPN)

Cosmo Pharmaceuticals Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 7, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,199	818	1,003	1,105	1,229	1,122
Market Cap Growth	52.94%	-18.39%	-9.22%	-10.15%	9.61%	-14.94%
Enterprise Value	1,078	780	962	1,066	1,154	944
Last Close Price	74.70	49.51	58.31	61.34	79.48	71.72
PE Ratio	17.96	-173.70	56.26	46.15	-134.50	-39.54
PS Ratio	6.73	9.48	9.94	16.37	18.64	16.51
PB Ratio	2.50	2.05	2.19	2.08	2.84	2.62
P/FCF Ratio	10.92	29.04	35.34	149.55	128.14	-48.93
P/OCF Ratio	9.96	26.15	30.54	84.48	87.48	-54.76
EV/Sales Ratio	6.04	9.03	9.54	15.80	17.50	13.89
EV/EBITDA Ratio	11.13	42.51	23.65	57.74	176.12	-101.66
EV/EBIT Ratio	13.03	136.27	34.71	92.64	590.89	-70.55
EV/FCF Ratio	9.82	27.66	33.92	144.35	120.31	-41.16
Debt / Equity Ratio	0.00	0.00	0.37	0.33	0.42	0.42
Debt / EBITDA Ratio	0.01	0.09	4.14	9.20	24.49	-
Debt / FCF Ratio	0.01	0.06	6.05	23.85	18.97	-7.82
Asset Turnover	0.27	0.14	0.13	0.09	0.10	0.10
Inventory Turnover	3.19	3.06	3.29	3.50	4.66	4.97
Quick Ratio	4.35	3.15	1.45	11.77	11.06	18.39
Current Ratio	4.85	3.98	1.57	12.99	11.60	19.25
Return on Equity (ROE)	14.80%	-1.06%	3.59%	4.75%	-1.99%	-5.84%
Return on Assets (ROA)	7.82%	0.58%	2.24%	0.99%	0.19%	-1.27%
Return on Capital (ROIC)	9.59%	0.72%	2.66%	1.11%	0.20%	-1.32%
Earnings Yield	5.95%	-0.56%	1.70%	2.03%	-0.70%	-2.37%
FCF Yield	9.75%	3.44%	2.83%	0.67%	0.78%	-2.04%
Dividend Yield	2.51%	3.76%	1.78%	1.61%	-	-
Payout Ratio	6.07%	-	90.61%	-	-	-
Buyback Yield / Dilution	0.77%	1.95%	2.83%	-16.81%	1.11%	2.48%
Total Shareholder Return	3.29%	5.71%	4.61%	-15.21%	1.11%	2.48%

Source: S&P Capital IQ. Standard template. Financial Sources.